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Abstract
6-Mercaptopurine is an antimetabolite antineoplastic agent. The objective of the study was to evaluate the impact of 
the Trivedi Effect®-Consciousness Energy Healing Treatment on physicochemical and thermal properties of 6-mercaptopurine 
using the modern analytical technique. The 6-mercaptopurine sample was divided into two parts, one part of mercaptopurine 
was considered as a control sample, while the other part was subjected to the Biofield Treatment remotely by a renowned 
Biofield Energy Healer, Alice Branton and termed as a treated sample. The PXRD peak intensities and crystallite sizes were 
significantly altered ranging from -63.38% to 3.85% and -55.26% to 228.26%, respectively, whereas the average crystallite 
size was significantly increased by 8.16% in the treated mercaptopurine compared with the control sample. The particle size 
values were significantly decreased by 26.63% (d10), 24.43% (d50), 17.56% (d90), and 21.41% [D (4,3)] and the specific surface 
area was significantly increased by 38.57% in the treated sample compared to the control sample. The latent heat of fusion was 
significantly increased by 49.97% in the treated sample compared to the control sample. The total weight loss was decreased by 
11.45%; whereas the residue amount was significantly increased by 160.07% in the treated sample compared with the control 
sample. The results indicated that the Trivedi Effect® might lead to the generation of a new polymorphic form of mercaptopurine 
which would offer better solubility, absorption, and bioavailability compared with the control sample, which would be useful in 
designing novel pharmaceutical formulations for the better therapeutic responses against leukemia, Crohn’s disease, ulcerative 
colitis, etc. 
Keywords: Consciousness Energy Healing Treatment; DSC; 
Particle Size; Surface Area; TGA/DTG PXRD; The Trivedi 
Effect®; 6-Mercaptopurine 
Introduction
6-mercaptopurine is an antimetabolite antineoplastic agent. 
It has immunosuppressant properties. The mechanism of action 
involves interference with nucleic acid synthesis by inhibiting 
purine metabolism [1,2].  It is used as a medication for cancer and 
autoimmune diseases, i.e., acute lymphocytic leukaemia, chronic 
myeloid leukaemia, Crohn’s disease, and ulcerative colitis [3-5]. It 
was approved for medical use in the United States since 1953 and 
also listed as Essential Medicines by the World Health Organization 
[6]. Common side effects associated with the mercaptopurine 
therapy are diarrhoea, nausea, vomiting, loss of appetite, mouth 
sores, stomach and abdominal pain, fatigue, weakness, fever, 
sore throat, skin rash, pinpoint red spots on the skin, darkening 
of the skin, yellowing of eyes or skin, hair loss, easy bruising or 
bleeding, dark urine, black or tarry stools, bloody stools, bloody 
urine, painful or difficult urination, may suppress the production 
of blood cells (both white and red blood cells) and can be linked 
to the genetic polymorphisms [7-9]. Mercaptopurine is used in 
the pharmaceutical formulations for oral medications in the form 
of tablets and in liquid suspension [10-12]. Mercaptopurine is 
insoluble in water, acetone, chloroform, and diethyl ether, but 
slightly soluble in dilute sulphuric acid; and soluble in hot alcohol 
and dilute alkali solutions [12]. Many scientific communities 
throughout the globe are researching ways to improve solubility, 
dissolution, absorption, and bioavailability of pharmaceutical and 
nutraceutical compounds because the physicochemical properties 
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of pharmaceutical or nutraceutical compounds are very important 
[13]. 
The Trivedi Effect®-Biofield Energy Healing Treatment has 
shown a significant impact in the alterations of physicochemical 
properties such as crystallite size, particle size, surface area, 
thermal behaviour, and bioavailability profile of pharmaceutical 
and nutraceutical compounds [14-18]. Every living organism 
possesses a unique para-dimensional electromagnetic field around 
the body which generated from the continuous movement of the 
electrically charged particles (ions, cells, etc.), blood flow, and heart 
moments inside the body known as “Biofield” (Putative Energy 
Field). The Trivedi Effect® (Biofield Energy) is a natural and is 
the only scientifically proven phenomenon in which a person can 
harness this inherently intelligent energy from the Universe and 
transmit it anywhere on the planet through the possible mediation 
of neutrinos [19]. Due to the increasing beneficial effects of 
Complementary and Alternative Medicine (CAM) therapies and 
integrative healthcare approaches including the Biofield Energy 
Therapies, alternative medicine is an emerging field treatment 
methods against various health conditions [20,21]. CAM therapies 
has been recognized by National Center of Complementary and 
Integrative Health (NCCIH) along with other therapies, which 
include Ayurvedic medicine, naturopathy, homeopathy, Tai 
Chi, Qi Gong, acupuncture, acupressure, healing touch, Reiki, 
hypnotherapy, Rolfing, etc. The CAM has been accepted by 
the most of the U.S. population because of several advantages 
[22,23]. 
Similarly, the Trivedi Effect®-Consciousness Energy 
Healing Treatment has significant impact on the transformation 
in non-living materials and living organisms, and the outcomes 
were published in numerous peer-reviewed scientific journals. The 
Trivedi Effect®-Biofield Energy Treatment has the unprecedented 
capability to transform the physicochemical, structural, and 
behavioural properties of organic compounds [24,25], metals 
[26,27], ceramics [28], polymers [29], microorganisms [30,31], 
living cells [32,33], to improve the overall productivity of crops 
[34,35], and alter several qualities of metals and ceramics [36,37]. 
Alice Branton (the USA) is a renowned Biofield Energy Healer. 
She has the ability to harness Life Force from nature and transmit 
it to living and non-living object(s), anywhere in the world through 
thought intention, to change their characteristics, transform their 
behaviour and enhance their function. She is on a mission to 
winner the breakthrough science of Life Force Energy and its 
applications in pharmaceutical and nutraceuticals product research 
to usher in a new era of human health and wellness. The current 
study was carried out to evaluate the impact of the Trivedi Effect®-
Consciousness Energy Healing Treatment by Alice Branton on 
the physicochemical, thermal, and behavioural properties of 
6-mercaptopurine using powder x-ray diffraction (PXRD), particle 
size analysis (PSA), differential scanning calorimetry (DSC), and 
thermogravimetric analysis (TGA)/ differential thermogravimetric 
analysis (DTG).
Materials and Methods 
Chemicals and Reagents
6-Mercaptopurine monohydrate was purchased from Tokyo 
Chemical Industry Co., Ltd., Japan. All other chemicals used during 
the experiments were of analytical grade available in India.
Consciousness Energy Healing Treatment Strategies
6-mercaptopurine was the test sample for the experiment, 
which divided into two equal parts. One part of mercaptopurine 
was treated with The Trivedi Effect®-Energy of Consciousness 
Healing Treatment remotely under standard laboratory conditions 
for 3 minutes and known as The Trivedi Effect® Treated (or Biofield 
Energy Treated) sample. This Biofield Energy Treatment was 
provided through the healer’s unique energy transmission process 
by the renowned Biofield Energy Healer, Alice Branton, USA, to 
the mercaptopurine. However, the second part of mercaptopurine 
was considered as a control sample (to this no Biofield Energy 
Treatment was provided). Further, the control sample was treated 
with a “sham” healer for the comparison purposes. The “sham” 
healer did not have any knowledge about the Biofield Energy 
Treatment. After treatment, the Biofield Energy Treated and 
untreated samples were kept in sealed conditions and characterized 
using PXRD, PSA, DSC, and TGA techniques.   
Characterization
Powder X-ray Diffraction (PXRD) Analysis
The PXRD analysis of mercaptopurine was performed with 
the help of Rigaku MiniFlex-II Desktop X-ray diffractometer 
(Japan) [38,39]. The Cu Kα radiation source tube output voltage 
used was 30 kV, and tube output current was 15 mA. Scans were 
performed at room temperature. The average size of individual 
crystallites was calculated from PXRD data using the Scherrer’s 
formula (1):
  G = kλ/βcosθ  (1)
Where k is the equipment constant (0.94), G is the crystallite 
size in nm, λ is the radiation wavelength (0.154056 nm for Kα1 
emission), β is the full-width at half maximum (FWHM), and θ is 
the Bragg angle [40].
The percent change in crystallite size (G) of mercaptopurine was 
calculated using the following equation 2:
       (2)
Where GControl and GTreated are the crystallite size of the control and 
the Biofield Energy Treated samples, respectively.
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Particle Size Analysis (PSA)
The particle size analysis of mercaptopurine was conducted 
on Malvern Mastersizer 2000, (UK) with a detection range 
between 0.01 µm to 3000 µm using wet method [41,42]. The 
sample unit (Hydro MV) was filled with a dispersant medium 
(sunflower oil) and operated the stirrer at 2500 rpm. The PSA 
analysis of mercaptopurine was performed to obtain the average 
particle size distribution. Where d (0.1) μm, d (0.5) μm, d (0.9) μm 
represent particle diameter corresponding to 10%,50% and 90% of 
the cumulative distribution. D(4,3) represents the average mass-
volume diameter, and SSA is the specific surface area (m2/g). The 
calculations were done by using software Mastersizer Ver. 5.54.
The percent change in particle size (d) for mercaptopurine at 
below 10% level (d10), 50% level (d50), 90% level (d90), and D (4,3) 
was calculated using the following equation 3:
      (3)
Where dControl and dTreated are the particle size (μm) for at below 
10% level (d10), 50% level (d50), and 90% level (d90) of the control 
and the Biofield Energy Treated samples, respectively.
The percent change in surface area (S) was calculated using 
the following equation 4:
      (4)
Where SControl and STreated are the surface area of the control 
and the Biofield Energy Treated mercaptopurine, respectively.
Differential Scanning Calorimetry (DSC) 
The DSC analysis of mercaptopurine was performed with 
the help of DSC Q200, TA instruments. The sample of ~1-2 mg 
was loaded to the aluminium sample pan at a heating rate of 10ºC/
min from 30°C to 350°C [41,42]. The % change in melting point 
(T) was calculated using the following equation 5:
      (5)
Where TControl and TTreated are the melting point of the control 
and treated samples, respectively.
The percent change in the latent heat of fusion (ΔH) was 
calculated using the following equation 6:
     (6)
Where ΔHControl and ΔHTreated are the latent heat of fusion of 
the control and treated mercaptopurine, respectively.
Thermal Gravimetric Analysis (TGA) / Differential 
Thermogravimetric Analysis (DTG)
TGA/DTG thermograms of mercaptopurine were obtained 
with the help of TGA Q50 TA instruments. The sample of ~2-5 
mg was loaded to the platinum crucible at a heating rate of 10ºC/
min from 25°C to 1000°C with the recent literature [41,42]. The 
% change in weight loss (W) was calculated using the following 
equation 7:
       (7)
Where WControl and WTreated are the weight loss of the control 
and the Biofield Energy Treated mercaptopurine, respectively.
The % change in maximum thermal degradation temperature 
(Tmax) (M) was calculated using the following equation 8:
      (8)
Where M Control and M Treated are the T max values of the control 
and the Biofield Energy Treated mercaptopurine, respectively.
Results and Discussion
Powder X-ray Diffraction (PXRD) Analysis 
The PXRD diffractograms of the control and the Biofield 
Energy Treated sample showed sharp and intense peaks (Figure 1). 
These sharp and intense peaks in the chromatograms indicated that 
both the samples were crystalline. The PXRD diffractograms of the 
control and the Biofield Energy Treated mercaptopurine samples 
showed the highest peak intensity at 2θ near to 27.47° and 27.36° 
(Table 1, entry 10). The peak intensities of the Biofield Energy 
Treated mercaptopurine were significantly altered compared to 
the control sample. Overall, the peak intensities of the Biofield 
Energy Treated sample were significantly altered in the range 
from -63.38% to 3.85% compared to the control sample (Table 1). 
Likewise, the crystallite sizes of the Biofield Energy Treated sample 
were significantly altered in the range from -55.26% to 228.26% 
compared to the control sample (Table 1). Overall, the average 
crystallite size of the Biofield Energy Treated mercaptopurine 
(320.65 nm) was significantly increased by 8.16% compared with 
the control sample (296.45 nm) (Table 1).
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Figure 1: PXRD diffractograms of the control and the Biofield Energy Treated mercaptopurine.
Entry No.
Bragg angle (°2θ) Peak Intensity (%) Crystallite size (G, nm)
Control Treated Control Treated % change a Control Treated % change b
1 11.68 11.55 140 128 -8.57 311 321 3.22
2 12.73 12.64 39 34 -12.82 789 353 -55.26
3 14.48 14.37 364 378 3.85 297 347 16.84
4 15.24 15.15 59 52 -11.86 319 400 25.39
5 16.69 16.6 45 37 -17.78 298 341 14.43
6 20.48 20.39 87 84 -3.45 261 303 16.09
7 21.04 20.94 61 62 1.64 269 313 16.36
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8 23.41 23.34 209 181 -13.40 289 345 19.38
9 25.75 25.67 139 140 0.72 287 372 29.62
10 27.47 27.36 457 395 -13.57 291 313 7.56
11 29.34 29.22 208 198 -4.81 268 274 2.24
12 30.32 30.21 160 141 -11.88 280 308 10.00
13 32.37 32.24 57 58 1.75 292 478 63.70
14 33.89 33.85 62 60 -3.23 268 316 17.91
15 35.81 35.71 91 57 -37.36 263 283 7.60
16 39.35 39.32 60 47 -21.67 267 413 54.68
17 42.24 42.22 22 13 -40.91 489 453 -7.36
18 46.39 46.29 35 30 -14.29 244 220 -9.84
19 48.06 47.66 72 62 -13.89 101 109 7.92
20 56.74 55.57 71 26 -63.38 46 151 228.26
21 Average crystallite size 296.45 320.65 8.16
adenotes the percentage change in the peak intensity of the Biofield Energy Treated sample with respect to the control sample; 
bdenotes the percentage change in the crystallite size of the Biofield Energy Treated sample with respect to the control sample.
Table 1: PXRD data for the control and the Bio field Energy Treated mercaptopurine.
The peak intensity of each diffraction face on the crystalline 
compound changes according to the crystal morphology [43] and 
alterations in the PXRD pattern provide the proof of polymorphic 
transitions [44,45]. Therefore, any change observed in the crystallite 
sizes and peak intensities indicated the modification of the crystal 
morphology of the Biofield Energy Treated mercaptopurine 
compared to the control sample. The Trivedi Effect®-Consciousness 
Energy Healing Treatment probably produced a new polymorphic 
form of mercaptopurine through the Biofield Energy via neutrino 
oscillations [19]. Different polymorphic forms of pharmaceuticals 
have the significant effects on the drug performance, such as 
bioavailability, therapeutic efficacy, and toxicity, because of their 
thermodynamic and physicochemical properties like melting 
point, energy, stability, and especially solubility, are different from 
the original form [46,47]. Thus, it can be assumed that the Trivedi 
Effect® Treated mercaptopurine would be more efficacious in 
pharmaceutical formulations.
Particle Size Analysis (PSA)
The particle size distribution analysis of both the samples was 
performed to analyse the change in the particle size, and surface 
area of the Biofield Energy Treated mercaptopurine compared to 
the control sample, and the data are presented in (Table 2). The 
particle size values of the control mercaptopurine at d10, d50, d90, 
and D (4,3) were 34.82 µm, 99.13 µm, 190.68 µm, and 107.03 µm, 
respectively. Similarly, the particle sizes of the Biofield Energy 
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Treated mercaptopurine at d10, d50, d90, and D (4,3) were 25.55 µm, 
74.91 µm, 157.20 µm, and 84.11 µm, respectively. The particle 
size values in the Biofield Energy Treated mercaptopurine were 
significantly decreased at d10, d50, d90, and D (4,3) by 26.63%, 
24.43%, 17.56%, and 21.41% compared to the control sample. 
Therefore, the specific surface area of the Biofield Energy Treated 
mercaptopurine (0.134 m2/g) was significantly increased by 38.57% 
compared to the control sample (0.0967 m2/g). Hence, it can be 
assumed that the Trivedi Effect®-Consciousness Energy Healing 
Treatment might act as an external force for the conversion of the 
larger particles into smaller particles, thus increasing the surface 
area. It was reported that the particle size, shape, and surface area 
impact the solubility, dissolution rate, absorption, bioavailability, 
and even the therapeutic efficacy of a drug [47,48]. The solubility of 
mercaptopurine is almost insoluble in water, acetone, chloroform, 
and diethyl ether, whereas slightly soluble in dilute sulphuric 
acid; soluble in hot alcohol and dilute alkali solutions [12]. Thus, 
it is anticipated that the Biofield Energy Treated mercaptopurine 
would show the better therapeutic properties in pharmaceutical 
formulations by increasing solubility, dissolution, and absorption, 
which would be better for the pharmaceutical industry when used 
as a raw material for manufacturing.
Parameter d10 (µm) d50 (µm) d90 (µm) D(4,3) (µm) SSA (m2/g)
Control 34.82 99.13 190.68 107.03 0.0967
Biofield Treated 25.55 74.91 157.20 84.11 0.134
Percent change* (%) -26.63 -24.43 -17.56 -21.41 38.57
d10, d50, and d90: particle diameter corresponding to 10%, 50%, and 90% of the cumulative distribution, D (4,3): the average mass-volume diameter, 
and SSA: the specific surface area. 
*denotes the percentage change in the Particle size distribution of the Biofield Energy Treated sample with respect to the control sample.
Table 2: Particle size distribution of the control and the Biofield Energy Treated mercaptopurine.
Differential Scanning Calorimetry (DSC) Analysis 
DSC thermograms of both control and the Biofield 
Energy Treated mercaptopurine are presented in (Figure 2). 
The DSC thermograms of the control and the Biofield Energy 
Treated mercaptopurine showed two sharp endothermic peaks 
in the thermograms (Figure 2). The 1st peak indicated the peak 
of evaporation of the bounded water from 6-mercaptopurine 
monohydrate. Similarly, the 2nd peak indicated the melting point 
of 6-mercaptopurine. The thermogram pattern and melting point 
closely matched to the literature reported data [49]. The evaporation 
and melting point of the Biofield Energy Treated mercaptopurine 
were slightly altered by 0.49% and -0.44%, respectively compared 
with the control sample (Table 3). 
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Figure 2: DSC thermograms of the control and the Biofield Energy Treated mercaptopurine.
Sample Evaporation Temp (°C) Melting Point (°C)
∆H (J/g)
Evaporation Fusion
Control Sample 174.71 329.31 307.8 98.35
Biofield Energy Treated 175.57 327.87 303.3 147.50
% Change* 0.49 -0.44 -1.46 49.97
ΔH: Latent heat of evaporation/decomposition;
*denotes the percentage change of the Biofield Energy Treated mercaptopurine with respect to the control sample.
Table 3: DSC data for both control and the Bio field Energy Treated samples of mercaptopurine.
The latent heat of evaporation (∆Evaporation) of the Bio Field 
Energy Treated mercaptopurine (303.3 J/g) was slightly decreased 
by 1.46% compared with the control sample (307.8 J/g) (Table 3). 
However, the latent heat of fusion (∆Hfusion) of the Bio Field Energy 
Treated mercaptopurine (147.5 J/g) was significantly increased by 
49.97% compared with the control sample (98.35 J/g) (Table 3). 
As per the literature, any change in the latent heat of fusion can 
be attributed to the disrupted molecular chains and the crystal 
structure [50]. Thus, it can be predicted that the Trivedi Effect®-
Consciousness Energy Healing Treatment might be responsible 
for the disruption of the molecular chains and crystal structure of 
mercaptopurine. The evaporation and melting temperatures of the 
Biofield Energy Treated samples did not alter much compared to 
the control sample, but the significant increase in the latent heat of 
fusion indicated that the thermal stability of the Biofield Energy 
Treated sample was increased compared to the control sample.
Thermal Gravimetric Analysis (TGA)/Differential 
Thermogravimetric Analysis (DTG)
The TGA thermograms of the control and the Biofield 
Energy Treated mercaptopurine samples showed three steps of 
thermal degradation (Figure 3). The total weight loss of the Biofield 
Citation: Branton A, Trivedi MK, Trivedi D, Nayak G, Jana S (2018) The Effect of Consciousness Energy Healing Treatment on Physicochemical and Thermal Properties 
of 6-Mercaptopurine. Arch Nat Med Chem: ANMC-118. DOI: 10.29011/ANMC-118. 000018
8 Volume 2018; Issue 02
Arch Nat Med Chem, an open access journal 
ISSN: 2577-0195
Energy Treated mercaptopurine was decreased by 11.45% compared to the control sample (Table 4). Therefore, the residue amount was 
significantly increased by 160.07% in the Biofield Energy Treated mercaptopurine compared to the control sample (Table 4).
Sample
TGA DTG; Tmax (°C)
Total weight loss (%) Residue % 1st Peak 2nd Peak 3rd Peak
Control 93.33 6.68 164.45 335.8 676.1
Biofield Energy Treated 82.64 17.36 160.73 334.3 678.3
% Change* -11.45 160.07 -2.26 -0.46 0.33
*denotes the percentage change of the Biofield Energy Treated sample with respect to the control sample;
Tmax = the temperature at which maximum weight loss takes place in TG or peak temperature in DTG;
Table 4: TGA/DTG data of the control and the Biofield Energy Treated samples of mercaptopurine.
The DTG of the control and the Biofield Energy Treated mercaptopurine also showed three peaks in the thermograms (Figure 
4). The maximum thermal degradation temperature (Tmax) of the 1
st, 2nd and 3rd peaks of the Biofield Energy Treated sample altered 
by -2.26%, -0.46%, and 0.33% compared with the control sample (Table 4). Overall, TGA/DTG analysis of mercaptopurine samples 
revealed that the thermal stability of the Biofield Energy Treated sample was increased compared with the control sample. The improved 
thermal stability would improve the quality and self-life of mercaptopurine in the pharmaceutical formulations.
Figure 3: TGA thermograms of the control and the Biofield Energy Treated mercaptopurine.
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Figure 4: DTG thermograms of the control and the Biofield Energy 
Treated mercaptopurine.
Conclusion
The experimental results confirmed that the Trivedi Effect®-
Consciousness Energy Healing Treatment has significant effects 
on the particle size, surface area, and thermal properties of 
6-mercaptopurine. The PXRD analysis indicated that the peak 
intensities and crystallite sizes of the Biofield Energy Treated 
mercaptopurine were significantly altered in the range from 
-63.38% to 3.85% and -55.26% to 228.26%, respectively compared 
to the control sample. The average crystallite size of the Biofield 
Energy Treated mercaptopurine was significantly increased by 
8.16% compared with the control sample. The particle size values 
in the Biofield Energy Treated mercaptopurine were significantly 
decreased by 26.63%, 24.43%, 17.56%, and 21.41% at d10, d50, d90, 
and D (4,3) compared to the control sample. Therefore, the specific 
surface area of the Biofield Energy Treated mercaptopurine was 
significantly increased by 38.57% compared to the control sample. 
The significant increase in the ∆Hfusion by 49.97% in the Biofield 
Energy Treated mercaptopurine indicated that the thermal stability 
of the Biofield Energy Treated sample was more compared to the 
control sample. The total weight loss was decreased by 11.45%; 
however, the residue amount was significantly increased by 
160.07% in the Biofield Energy Treated sample compared with the 
control sample. The Trivedi Effect®-Consciousness Energy Healing 
Treatment might lead to the generation of a new polymorphic form 
of mercaptopurine which would offer better solubility, dissolution, 
absorption, and bioavailability compared with the control sample. 
The Trivedi Effect®-Consciousness Energy Healing Treated 
mercaptopurine would be more efficacious in pharmaceutical 
formulations that might offer better therapeutic response against 
acute lymphocytic leukemia, chronic myeloid leukemia, Crohn’s 
disease, and ulcerative colitis, etc.
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